JUNE HARRY: Open Payments
NPI 1104384957 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 48 payments from 7 companies in 2025. Trend: 2023 $1,778 · 2024 $1,030 · 2025 $1,388
Food & beverage: $1,388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $478 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $247 |
| Lilly USA, LLC | 17 | $222 |
| Novo Nordisk Inc | 5 | $219 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $90 |
| Tandem Diabetes Care, Inc. | 1 | $73 |
| GlaxoSmithKline, LLC. | 3 | $59 |
Products named: JARDIANCE, CREON, LINZESS, Ozempic, MOUNJARO, XIFAXAN, t:slim X2 Insulin Pump with Control-IQ, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
